Astrid Magenau
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.
Journal: Science advances
Published: March 12, 2025
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response.
Journal: Science advances
Published: July 03, 2024
Cell-derived Matrix Assays to Assess Extracellular Matrix Architecture and Track Cell Movement.
Journal: Bio-protocol
Published: June 20, 2022
Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status.
Journal: Science advances
Published: September 29, 2021
ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling.
Journal: Nature communications
Published: March 26, 2018
Removing physiological motion from intravital and clinical functional imaging data.
Journal: eLife
Published: February 09, 2018
Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pancreatic Cancer.
Journal: Cell reports
Published: November 29, 2017
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.
Journal: Science translational medicine
Published: September 06, 2016
Distinct surveillance pathway for immunopathology during acute infection via autophagy and SR-BI.
Journal: Scientific reports
Published: April 04, 2016
Last Updated: 09/26/2026